Revenue Growth in Q1
Q1 net sales of approximately $3.36 billion, up 7.7% year-over-year, reflecting balanced contribution from active customer growth and NSPAC expansion.
Active Customer and NSPAC Expansion
Ended Q1 with 21.5 million active customers (+3.6% YoY). NSPAC was $597 in Q1, up ~4.6% year-over-year on a normalized basis (adjusting for an extra week in the prior year).
Autoship Strength and Recurring Revenue Mix
Autoship customer sales reached ~$2.83 billion in Q1, increasing >10% YoY and representing 84.4% of total net sales, reinforcing recurring revenue durability and predictability.
Margin Expansion and Adjusted EBITDA
Q1 adjusted EBITDA was approximately $253 million, with an adjusted EBITDA margin of 7.5%, reflecting ~130 basis points of year-over-year expansion and >25% adjusted EBITDA flow-through.
Gross Margin and SG&A Leverage
Reported gross margin of 30.1% in Q1 (+50 basis points YoY). Non-GAAP SG&A was ~$593 million (17.7% of net sales) and delivered ~90 basis points of year-over-year SG&A leverage.
Profitability and EPS
Q1 adjusted net income of approximately $180 million and adjusted diluted EPS of $0.43, demonstrating profitable growth at scale.
Free Cash Flow and Cash Position
Q1 free cash flow of approximately $71 million, an increase of >45% year-over-year. Ended quarter with ~$520 million in cash and marketable securities and over $1 billion of total available liquidity.
Strategic M&A and Clinic Expansion
Closed SmartPak acquisition (expected ~ $80 million net sales contribution in FY2026) and subsequently closed Modern Animal. Chewy expects to operate ~60 clinics exiting FY2026 with embedded steady-state revenue contribution approaching ~$290 million.
Capital Allocation and Leverage Actions
Deployed ~ $200 million in share repurchases during the quarter and launched a $600 million Term Loan B to enhance financial flexibility while targeting net leverage below 2x adjusted EBITDA over time.
AI and Productivity Roadmap
Embedding AI across customer service, pharmacy, fulfillment and marketing. Expect AI-driven efficiencies to deliver low tens of millions of dollars of benefit in FY2026 with a meaningful ramp (>$50 million) expected in FY2027.